{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:59:38Z","timestamp":1790085578142,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003134","name":"Fund for Research and Training in Industry and Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010527","name":"Universite Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018003","name":"Friends of the Instituts Pasteur in Brussels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["project grant PTJ-195736"],"award-info":[{"award-number":["project grant PTJ-195736"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["\\u201CPDR\\u201D grant"],"award-info":[{"award-number":["\\u201CPDR\\u201D grant"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["\\u201CAspirant\\u201D PhD fellowship"],"award-info":[{"award-number":["\\u201CAspirant\\u201D PhD fellowship"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["\\u201CAspirant\\u201D fellowship"],"award-info":[{"award-number":["\\u201CAspirant\\u201D fellowship"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["post-doctoral fellowship from a \\u201CPDR\\u201D grant"],"award-info":[{"award-number":["post-doctoral fellowship from a \\u201CPDR\\u201D grant"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119866","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:40:07Z","timestamp":1788378007000},"page":"119866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["(+)-Catechin:lysine 1:2 promotes HIV-1 quiescence through a biphasic and dose-dependent mechanism: Implications for block-and-lock cure strategies"],"prefix":"10.1016","volume":"203","author":[{"given":"Maryam","family":"Bendoumou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Nestola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Dutilleul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pilosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Niebes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"Burny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coca","family":"Necsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"De Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Van Lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6684","key":"10.1016\/j.biopha.2026.119866_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.adk1831","article-title":"HIV cure: the daunting scale of the problem","volume":"383","author":"Siliciano","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119866_bib2","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.3389\/fmicb.2019.03060","article-title":"Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs","volume":"10","author":"Ait-Ammar","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2026.119866_bib3","article-title":"The reservoir of latent HIV","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2026.119866_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101438","article-title":"HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs","volume":"51","author":"Fromentin","year":"2021","journal-title":"Semin. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119866_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/COH.0000000000000851","article-title":"The multifaceted nature of HIV tissue reservoirs","volume":"19","author":"Banga","year":"2024","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"12","key":"10.1016\/j.biopha.2026.119866_bib6","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3390\/v12121385","article-title":"Depicting HIV-1 transcriptional mechanisms: a summary of what we know","volume":"12","author":"Dutilleul","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.biopha.2026.119866_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-virology-091919-103029","article-title":"The current status of latency reversing agents for HIV-1 remission","volume":"8","author":"Rodari","year":"2021","journal-title":"Annu. Rev. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119866_bib8","first-page":"9","article-title":"Latency-reversing agents: where are we now?","volume":"21","author":"Bendoumou","year":"2025","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.biopha.2026.119866_bib9","article-title":"EDITORIAL: putting HIV in the big sleep with the block-and-lock strategy","volume":"19","author":"Eline","year":"2024","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.biopha.2026.119866_bib10","article-title":"The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review","volume":"9","author":"Debrabander","year":"2023","journal-title":"J. Virus Erad."},{"issue":"3","key":"10.1016\/j.biopha.2026.119866_bib11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/molecules30030654","article-title":"Epigallocatechin Gallate (EGCG): pharmacological properties, biological activities and therapeutic potential","volume":"30","author":"Capasso","year":"2025","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2026.119866_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/carcin\/bgq285","article-title":"\u00ab (\u2212)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1\/p21 and p 16 INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells","volume":"32","author":"Nandakumar","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2026.119866_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1078642","article-title":"Targeting a transcription factor NF-\u03baB by green tea catechins using in silico and in vitro studies in pancreatic cancer","volume":"9","author":"Suhail","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.biopha.2026.119866_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108620","article-title":"The tea catechin epigallocatechin gallate inhibits NF-\u03baB-mediated transcriptional activation by covalent modification","volume":"695","author":"Lakshmi","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2026.119866_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114575","article-title":"Targeting the TNF-\u03b1\u2013TNFR interaction with EGCG to block NF-\u03baB signaling in human synovial fibroblasts","volume":"161","author":"Xu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.biopha.2026.119866_bib16","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00262-012-1301-x","article-title":"EGCG targeting efficacy of NF-\u03baB downstream gene products is dictated by the monocytic\/macrophagic differentiation status of promyelocytic leukemia cells","volume":"61","author":"V\u00e9zina","year":"2012","journal-title":"Cancer Immunol. Immunother. CII"},{"issue":"3","key":"10.1016\/j.biopha.2026.119866_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/156800911794519743","article-title":"Green tea polyphenols as proteasome inhibitors: implication in chemoprevention","volume":"11","author":"Yang","year":"2011","journal-title":"Curr. Cancer Drug. Targets"},{"issue":"10","key":"10.1016\/j.biopha.2026.119866_bib18","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3390\/molecules25102326","article-title":"Epigallocatechin-3-gallate (EGCG) alters histone acetylation and methylation and impacts chromatin architecture profile in human endothelial cells","volume":"25","author":"Ciesielski","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119866_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.redox.2013.12.022","article-title":"New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate","volume":"2","author":"Kim","year":"2014","journal-title":"Redox Biol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119866_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30153128","article-title":"Catechins and Human Health: Breakthroughs from Clinical Trials","volume":"30","author":"Ferrari","year":"2025","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.biopha.2026.119866_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/foods10102277","article-title":"Antiviral properties of polyphenols from plants","volume":"10","author":"Chojnacka","year":"2021","journal-title":"Foods"},{"issue":"8","key":"10.1016\/j.biopha.2026.119866_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22081337","article-title":"A review of the antiviral role of green tea catechins","volume":"22","author":"Xu","year":"2017","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2026.119866_bib23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119866_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119866_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(01)00189-9","article-title":"Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)","volume":"53","author":"Yamaguchi","year":"2002","journal-title":"Antivir. Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119866_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949305","article-title":"PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK\/NF-\u03baB signaling","volume":"21","author":"Yang","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2026.119866_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103985","article-title":"Novel role of UHRF1 in the epigenetic repression of the latent HIV-1","volume":"79","author":"Verdikt","year":"2022","journal-title":"eBioMedicine"},{"issue":"9","key":"10.1016\/j.biopha.2026.119866_bib28","first-page":"2346","article-title":"Bioavailability of tea catechins and its improvement","volume":"23","author":"Cai","year":"2018","journal-title":"Mol. J. Synth. Chem. Nat. Prod. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2026.119866_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2025.100545","article-title":"Tea polyphenol epigallocatechin gallate and the gut\u2013health axis: unraveling structural characteristics, metabolic pathways, and systemic benefits","volume":"16","author":"Yang","year":"2025","journal-title":"Adv. Nutr."},{"issue":"9","key":"10.1016\/j.biopha.2026.119866_bib30","first-page":"2346","article-title":"Bioavailability of tea catechins and its improvement","volume":"23","author":"Cai","year":"2018","journal-title":"Mol. J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.biopha.2026.119866_bib31","unstructured":"P. Niebes et al., Salts of (+)-catechine, their preparation and use, and compositions containing these salts, US4285964A, 25 ao\u00fbt 1981 Consult\u00e9 le: 20 janvier 2026. [En ligne]. Disponible sur: https:\/\/patents.google.com\/patent\/US4285964A\/en."},{"issue":"1","key":"10.1016\/j.biopha.2026.119866_bib32","first-page":"118","article-title":"(+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the min\/+ mouse","volume":"61","author":"Weyant","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119866_bib33","unstructured":"P. Niebes, B.H. MAY, S. RACHIDI, J. Estager, et B. Schoentjes, Composition a base d\u2019un complexe de (+)-catechine et d\u2019acide amine pour le traitement et la prevention du cancer, EP2996688A1, 23 mars 2016 Consult\u00e9 le: 20 janvier 2026. [En ligne]. Disponible sur: https:\/\/patents.google.com\/patent\/EP2996688A1\/en?q=(bioavailabity)&inventor=Paul+Niebes."},{"key":"10.1016\/j.biopha.2026.119866_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00869","article-title":"(+)-Catechin in a 1:2 complex with lysine inhibits cancer cell migration and metastatic take in mice","volume":"8","author":"Payen","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119866_bib35","doi-asserted-by":"crossref","unstructured":"Preprint: E.N. Katsoulieris et A. Canas-Rodriguez, Catechin complexed with lysine has potent antitumor activities in human breast cancer xenograft model, 2 f\u00e9vrier 2021, bioRxiv. doi: 10.1101\/2021.02.01.429090.","DOI":"10.1101\/2021.02.01.429090"},{"key":"10.1016\/j.biopha.2026.119866_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172533","article-title":"Selective pro-apoptotic and antimigratory effects of polyphenol complex catechin:lysine 1:2 in breast, pancreatic and colorectal cancer cell lines","volume":"859","author":"Silva","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119866_bib37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/v15061377","article-title":"Antiviral activity of catechin against dengue virus infection","volume":"15","author":"Yi","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.biopha.2026.119866_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2007.07.001","article-title":"Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives","volume":"76","author":"Song","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2026.119866_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108953","article-title":"On the dual role of (+)-catechin as primary antioxidant and inhibitor of viral proteases","volume":"180","author":"Ciardullo","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119866_bib40","article-title":"FBS or BSA inhibits EGCG induced cell death through covalent binding and the reduction of intracellular ROS production","volume":"2016","author":"Zhang","year":"2016","journal-title":"BioMed. Res. Int."},{"issue":"4","key":"10.1016\/j.biopha.2026.119866_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/v9040064","article-title":"Targeting TNF and TNF receptor pathway in HIV-1 infection: from immune activation to viral reservoirs","volume":"9","author":"Pasquereau","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.biopha.2026.119866_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12977-016-0325-2","article-title":"HIV integration sites in latently infected cell lines: evidence of ongoing replication","volume":"14","author":"Symons","year":"2017","journal-title":"Retrovirology"},{"issue":"12","key":"10.1016\/j.biopha.2026.119866_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003834","article-title":"An in-depth comparison of latent hiv-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients","volume":"9","author":"Spina","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.biopha.2026.119866_bib44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41392-025-02424-3","article-title":"Retinol Binding Protein 4 reactivates latent HIV-1 by triggering canonical NF-\u03baB, JAK\/STAT5 and JNK signalling","volume":"10","author":"Pastorio","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119866_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12263-009-0148-z","article-title":"Improving the oral bioavailability of beneficial polyphenols through designed synergies","volume":"5","author":"Scheepens","year":"2010","journal-title":"Genes. Nutr."},{"issue":"9","key":"10.1016\/j.biopha.2026.119866_bib46","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/antiox10091471","article-title":"Synergy of the inhibitory action of polyphenols plus vitamin C on amyloid fibril formation: case study of human stefin B","volume":"10","author":"Jahi\u0107 Mujki\u0107","year":"2021","journal-title":"Antioxid. Basel Switz."},{"key":"10.1016\/j.biopha.2026.119866_bib47","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2147\/IJN.S59331","article-title":"Enhanced uptake and transport of (+)-catechin and (\u2212)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells","volume":"9","author":"Song","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.biopha.2026.119866_bib48","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/antiox11091746","article-title":"Cellular uptake of epigallocatechin gallate in comparison to its major oxidation products and their antioxidant capacity in vitro","volume":"11","author":"Alfke","year":"2022","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.biopha.2026.119866_bib49","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3945\/jn.110.134031","article-title":"Ascorbic acid offsets the inhibitory effect of bioactive dietary polyphenolic compounds on transepithelial iron transport in Caco-2 intestinal cells12","volume":"141","author":"Kim","year":"2011","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2026.119866_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.foodres.2009.08.016","article-title":"Formulation with ascorbic acid and sucrose modulates catechin bioavailability from green tea","volume":"43","author":"Peters","year":"2010","journal-title":"Food Res. Int. Ott. Ont."},{"issue":"2","key":"10.1016\/j.biopha.2026.119866_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15252\/emmm.201505557","article-title":"Sequential treatment with 5-aza-2\u2019-deoxycytidine and deacetylase inhibitors reactivates HIV-1","volume":"8","author":"Bouchat","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119866_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"Darcis","year":"2015","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.biopha.2026.119866_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8910396","article-title":"Oxidative stress during HIV infection: mechanisms and consequences","volume":"2016","author":"Ivanov","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.biopha.2026.119866_bib54","first-page":"597","article-title":"Reactive oxygen species in HIV infection","volume":"3","author":"Couret","year":"2016","journal-title":"EC Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119866_bib55","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013314","article-title":"Antioxidant nanozyme counteracts HIV-1 by modulating intracellular redox potential","volume":"13","author":"Singh","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2026.119866_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.682182","article-title":"Activation of the anti-oxidative stress response reactivates latent HIV-1 through the mitochondrial antiviral signaling protein isoform MiniMAVS","volume":"12","author":"Sarabia","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119866_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2018.09.001","article-title":"Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress","volume":"54","author":"Caro","year":"2019","journal-title":"Toxicol. Vitr. Int. J. Publ. Assoc. BIBRA"},{"issue":"3","key":"10.1016\/j.biopha.2026.119866_bib58","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/antiox12030754","article-title":"Beyond antioxidant activity: redox properties of catechins may affect changes in the DNA methylation profile\u2014the example of SRXN1 gene","volume":"12","author":"Jakubek","year":"2023","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.biopha.2026.119866_bib59","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.3390\/molecules27113453","article-title":"Concentration dependence of anti- and pro-oxidant activity of polyphenols as evaluated with a light-emitting Fe2+-Egta-H2O2 system","volume":"27","author":"Nowak","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2026.119866_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jcb.21417","article-title":"Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG","volume":"103","author":"Berletch","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.biopha.2026.119866_bib61","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1940-6207.CAPR-11-0009","article-title":"A novel prodrug of epigallocatechin-3-gallate: differential epigenetic htert repression in human breast cancer cells","volume":"4","author":"Meeran","year":"2011","journal-title":"Cancer Prev. Res. (Phila. Pa.)"},{"issue":"6","key":"10.1016\/j.biopha.2026.119866_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006093","article-title":"Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection","volume":"4","author":"Reuse","year":"2009","journal-title":"PLoS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:02:25Z","timestamp":1790082145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"alternative-id":["S0753332226009029"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119866","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(+)-Catechin:lysine 1:2 promotes HIV-1 quiescence through a biphasic and dose-dependent mechanism: Implications for block-and-lock cure strategies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119866"}}